Inogen (INGN) EBT (2013 - 2026)

Inogen (INGN) has 14 years of EBT data on file, last reported at -$8.5 million in Q1 2026.

• EBT for Q1 2026 came in at -$8.5 million, down 35.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.6 million (down 23.78% YoY), and the FY2025 annual result was -$23.4 million, up 19.78% from the prior year.
• EBT slipped to -$8.5 million in Q1 2026 per INGN's latest filing, from -$7.4 million in the prior quarter.
• Over five years, EBT peaked at $28.0 million in Q4 2022 and troughed at -$45.3 million in Q3 2023.
• A 5-year average of -$9.5 million and a median of -$7.4 million in 2025 frame the typical range for EBT.
• On a YoY basis, EBT climbed as much as 292.65% in 2022 and fell as far as 486.58% in 2022.
• A 5-year view of EBT shows it stood at $28.0 million in 2022, then tumbled by 196.91% to -$27.1 million in 2023, then surged by 89.83% to -$2.8 million in 2024, then sank by 167.36% to -$7.4 million in 2025, then declined by 15.41% to -$8.5 million in 2026.
• Business Quant data shows INGN's EBT at -$8.5 million in Q1 2026, -$7.4 million in Q4 2025, and -$5.4 million in Q3 2025.